Empowering Better PK/PD Decisions with Phoenix® WinNonlin® at SDC

How Do You Strengthen Your PK/PD Decisions?

In today’s accelerated clinical development environment, speed and precision are no longer tradeoffs—they’re expectations. Pharmacokinetic and pharmacodynamic (PK/PD) analyses play a critical role in shaping clinical decisions across early- and late-phase development, informing dose selection, exposure-response modeling, and supporting regulatory success.

That’s why SDC has complemented its PK/PD capabilities with cloud‑based Phoenix® WinNonlin®—a combination designed to deliver faster insights, greater reliability, and seamless compliance. This integrated approach enables more efficient clinical pharmacology workflows while maintaining the highest standards of data integrity.

So, how do you elevate PK/PD analysis without adding complexity? And how do you move faster without compromising quality or regulatory integrity? At SDC, we’ve built an answer rooted in expertise, innovation, and partnership.

Why Phoenix® WinNonlin®—and Why SDC?

Phoenix® WinNonlin® is the industry standard for PK/PD analysis, trusted globally and accepted by regulatory agencies including the FDA, EMA, and MHRA. But software alone doesn’t drive better decisions—people, processes, and infrastructure do.

At SDC, we pair Phoenix® WinNonlin® with deep PK scientific expertise to streamline workflows, efficiently support multiple studies and programs, and safeguard client data within a secure, centralized environment. Backed by scientific expertise, we identify common PK data issues early, mitigate potential delays, evaluate emerging trends, and ensure 21 CFR Part 11 compliance within a secure, validated workspace.

Curious how this could accelerate your drug development? Let’s take a closer look.

Faster Analyses. Smarter Workflows. Measurable Impact.

Time matters. Our enhanced PK/PD services are designed to reduce analysis timelines while increasing transparency and control across programs.

By running Phoenix® WinNonlin® analyses on a secure, validated platform, SDC clients can achieve 20–60% shorter run times.

Both centralized data handling and streamlined SDTM integration eliminate unnecessary rework and delays—freeing teams to focus on results, not logistics.

 With SDC’s integrated biostatistics, PK scientists, technology, and workflows operating as one team, sponsors often realize up to a 50% faster PK analysis, freeing time and resources for critical clinical and strategic decision‑making. 

PK/PD Expertise That Anticipates Challenges—Before They Cost You Time

One of the greatest risks in PK/PD analysis is discovering data issues too late. That’s where SDC’s scientific expertise makes the difference.

Our dedicated PK scientists:

• Identify common data issues early in the analysis process

• Evaluate trends across programs to proactively prevent repeat challenges

• Define clear, repeatable processes from data collection through final reporting

This proactive approach reduces downstream delays and helps ensure analyses are completed right the first time—supporting confident, timely decision‑making across studies and programs.

Built for Scale, Security, and Regulatory Confidence

As development programs grow more complex, so do the demands on PK/PD infrastructure. SDC’s enhanced capabilities are purpose‑built to scale—across multiple studies, programs, and clients—without compromising security or compliance.

Key advantages include:

• Secure separation of PK analyses from other study files to maintain clarity and control

• Centralized, validated workspaces with full audit trails

• 21 CFR Part 11–compliant processes supporting global regulatory submissions

• Streamlined data exchange for both standard and complex PK concentration datasets

Whether you’re preparing for a regulatory milestone or managing parallel studies, our approach ensures your PK/PD analyses are inspection‑ready and aligned with submission requirements.   

Beyond PK/PD Analysis: Partnership, Training, and Continuous Improvement

Empowering better clinical decisions doesn’t stop with deliverables. As a committed partner, SDC supports client teams with:

•    Best‑practice guidance for PK/PD analysis

•    Training to enhance internal capabilities

•    Expanding support for population PK analyses

Together, we create workflows that are not only efficient today—but adaptable to tomorrow’s development challenges.

 Ready to streamline your PK/PD analysis? 

With enhanced PK/PD expertise, advanced Phoenix® WinNonlin® capabilities, and secure cloud‑based infrastructure, SDC is better positioned than ever to support your clinical programs with precision, efficiency, and confidence.

Let’s connect—and empower PK/PD decisions, together.